These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 9584188)
1. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function. Schulman IG; Shao G; Heyman RA Mol Cell Biol; 1998 Jun; 18(6):3483-94. PubMed ID: 9584188 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466 [TBL] [Abstract][Full Text] [Related]
3. Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators. Yang W; Rachez C; Freedman LP Mol Cell Biol; 2000 Nov; 20(21):8008-17. PubMed ID: 11027271 [TBL] [Abstract][Full Text] [Related]
4. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444 [TBL] [Abstract][Full Text] [Related]
5. A regulatory role for RIP140 in nuclear receptor activation. Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662 [TBL] [Abstract][Full Text] [Related]
6. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor/retinoid X receptor heterodimers can be activated through both subunits providing a basis for synergistic transactivation and cellular differentiation. Botling J; Castro DS; Oberg F; Nilsson K; Perlmann T J Biol Chem; 1997 Apr; 272(14):9443-9. PubMed ID: 9083083 [TBL] [Abstract][Full Text] [Related]
8. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes. Marcus SL; Miyata KS; Rachubinski RA; Capone JP Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Jeyakumar M; Tanen MR; Bagchi MK Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239 [TBL] [Abstract][Full Text] [Related]
10. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR. Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690 [TBL] [Abstract][Full Text] [Related]
11. p120 acts as a specific coactivator for 9-cis-retinoic acid receptor (RXR) on peroxisome proliferator-activated receptor-gamma/RXR heterodimers. Monden T; Kishi M; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Yamada M; Mori M Mol Endocrinol; 1999 Oct; 13(10):1695-703. PubMed ID: 10517671 [TBL] [Abstract][Full Text] [Related]
12. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571 [TBL] [Abstract][Full Text] [Related]
13. Three amino acids specify coactivator choice by retinoid X receptors. Shao G; Heyman RA; Schulman IG Mol Endocrinol; 2000 Aug; 14(8):1198-209. PubMed ID: 10935544 [TBL] [Abstract][Full Text] [Related]
14. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer. Li D; Li T; Wang F; Tian H; Samuels HH Mol Cell Biol; 2002 Aug; 22(16):5782-92. PubMed ID: 12138189 [TBL] [Abstract][Full Text] [Related]
15. Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein. Wigren J; Surapureddi S; Olsson AG; Glass CK; Hammarström S; Söderström M J Endocrinol; 2003 May; 177(2):207-14. PubMed ID: 12740008 [TBL] [Abstract][Full Text] [Related]
16. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter. Palmer CN; Hsu MH; Muerhoff AS; Griffin KJ; Johnson EF J Biol Chem; 1994 Jul; 269(27):18083-9. PubMed ID: 8027069 [TBL] [Abstract][Full Text] [Related]
17. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA. Mouchon A; Delmotte MH; Formstecher P; Lefebvre P Mol Cell Biol; 1999 Apr; 19(4):3073-85. PubMed ID: 10082574 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies. Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. Eubank DW; Duplus E; Williams SC; Forest C; Beale EG J Biol Chem; 2001 Aug; 276(32):30561-9. PubMed ID: 11399762 [TBL] [Abstract][Full Text] [Related]
20. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Leesnitzer LM; Parks DJ; Bledsoe RK; Cobb JE; Collins JL; Consler TG; Davis RG; Hull-Ryde EA; Lenhard JM; Patel L; Plunket KD; Shenk JL; Stimmel JB; Therapontos C; Willson TM; Blanchard SG Biochemistry; 2002 May; 41(21):6640-50. PubMed ID: 12022867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]